WELCOME!
Prostate cancer is still a major health concern in the Western male population. Research efforts have increased steadily over the past two decades, and the funding of cancer research is competitive. It is, therefore, particularly remarkable that within the European Community based framework programme many prostate cancer consortia were funded in the last 5 years totalling approximately € 40 million. In all these collaborative efforts the translation of our understanding of prostate cancer development and progression to the bedside of the patient, plays a pivotal role.
So, it is time to present the highlights of these efforts in a unique event entitled “Prostate Cancer Translational Research in Europe’’. The unifying theme will be how today’s research will change the diagnosis and therapy of prostate cancer in the immediate future.
The European Association of Urology, provides an excellent forum to disseminate knowledge in specialized meetings. Therefore, the EAU Research Foundation has taken the initiative for this meeting. Top-speakers, were recruited from EC framework programs and we will invite researchers, EC officials and those representing the patient advocacy groups to attend. Furthermore, US based scientists will join to see how we can improve "across the pond’" collaboration.
|
|
|
Peter Mulders | Jack Schalken | Per-Anders Abrahamsson |
Chairman EAURF | PRIMA Consortium | EAU Secretary-General |
